PEOPLE - Organogenesis (US) makes appointment:
This article was originally published in Clinica
Organogenesis (Canton, Massachusetts), a developer and marketer of tissue engineered skin substitutes and bioengineered surgical products, has appointed Gary Gillheeney as vice-president of corporate development, CFO and treasurer. Mr Gillheeney previously served as CFO, secretary and treasurer at Innovative Clinical Solutions. He replaces John Arcari as CFO and treasurer.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.